Results from CANTAB in the Deep and Frequent Phenotyping Feasibility Study

The Deep and Frequent Phenotyping Study (DFP) is a multi-centre, observational study of prodromal Alzheimer’s disease (AD) and forms part of the Dementias Platform UK. The study includes a wide range of established and novel biomarkers and aims to identify a set of multi-modal markers for phenotyping prodromal AD, as part of the study, CANTAB cognitive tests are being used at multiple time points to assess changes in cognitive function. Prior to study initiation, a pilot study was conducted as a proof of concept to assess task suitability and participant acceptability of extensive and repeated phenotyping and the acceptability of the CANTAB tasks was also assessed in this feasibility study.

Download the poster presented at the Dementias Platform UK scientific meeting 2017.

Download

First name *

Last name *

Organisation / Institution *

Email *

Telephone *

Country *

Area of interest *

Where did you hear about us?

We would like to keep you informed with the latest news, data and innovations from the neuroscience and clinical trial community. We'll always treat your contact information with great care and will never allow other companies to access your information for marketing purposes.

Please let us know if you would like us to contact you or not by selecting one of the options below.

Yes please, I would like to stay up to date with the neuroscience research and clinical trial communities.

No thanks, I don't want to hear about the latest news, scientific data and technology innovations.

This field is intended to catch out spammers - please leave it blank.

Results from CANTAB in the Deep and Frequent Phenotyping Feasibility Study

Results from CANTAB in the Deep and Frequent Phenotyping Feasibility Study

Download

Download form

Share this